Sustained abstinence after a methamphetamine-specific treatment program for pregnant and parenting women
Open Access
- 25 September 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-8
Abstract
The treatment of methamphetamine use disorder (MUD) poses a significant challenge due to high rates of treatment discontinuation, substance use recurrence, and socioeconomic adversity. ‘Mummy, think of me’ (MAMADAM, an acronym from the German “Mama, denk an mich”), a treatment program specifically designed for pregnant women and young mothers with substance use disorders, has shown positive results regarding treatment efficacy and retention of child custody. This study aimed to evaluate the long-term sustainability of the MAMADAM intervention, which has not yet been examined. For this retrospective follow-up study, former patients with MUD who were pregnant and/or parenting women at the time of MAMADAM treatment were contacted by telephone. We analyzed whether self-reported abstinence after discharge from MAMADAM was associated with patient characteristics at admission to MAMADAM. Of the 114 eligible women, 39 participated in the follow-up interview, on average, 4.5 years after completing MAMADAM. Of these, 16 (41%) reported sustained abstinence from all addictive substances, excluding tobacco. At 12 and 18 months after discharge from MAMADAM, 9/39 (23%) and 11/39 (28%) women, respectively, reported at least one instance of substance use, including alcohol but excluding tobacco. Women who reported recurrences of substance use were significantly more likely to have more underage children, live apart from at least one minor, and consume methamphetamine for longer before MAMADAM than women with sustained abstinence. Cox regression, controlling for the duration of MAMADAM treatment, indicated that a longer history of methamphetamine use at admission to MAMADAM was associated with a shorter period of abstinence from all addictive substances (excluding tobacco) following discharge. The MAMADAM program is effective and sustainable in supporting long-term abstinence among pregnant and parenting women with MUD, indicating that pregnancy and parenthood can serve as turning points for promoting the necessary behavioral changes for recovery from addiction. Some women remain at elevated risk of relapse due to the vulnerabilities identified in this study. Future research should investigate whether stronger collaborations with government and community agencies can help these women maintain long-term abstinence.Keywords
Funding Information
- Technische Universität Dresden
This publication has 29 references indexed in Scilit:
- A probabilistic model of relapse in drug addictionMathematical Biosciences, 2024
- Risk factors for relapse among methamphetamine users receiving a joint legal–medical treatment program as a diversion intervention: A one-year follow-up studyJournal of Substance Use and Addiction Treatment, 2023
- Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newbornJournal of Perinatology, 2021
- The experiences of pregnant women attending a specialist service and using methamphetamineWomen and Birth, 2021
- 12- and 18-month follow-up after residential treatment of methamphetamine dependence: Influence of treatment drop-out and different treatment conceptsJournal of Psychiatric Research, 2020
- Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use DisorderJAMA Psychiatry, 2020
- „CrystalClean“ – Ein deutschsprachiges Manual zur qualifizierten Entgiftungs- und Motivationsbehandlung bei „Crystal Meth“-Abhängigkeit – Durchführbarkeit und AkzeptanzPsychiatrische Praxis, 2020
- „Mama denk’ an mich“ (MAMADAM) – ein multimodales Therapieprogramm für suchtkranke Schwangere, Mütter und Väter im Rahmen der psychiatrischen InstitutsambulanzSUCHT, 2018
- Time to relapse following treatment for methamphetamine use: A long-term perspective on patterns and predictorsDrug and Alcohol Dependence, 2014
- Effectiveness and sustainability of residential substance abuse treatment programs for pregnant and parenting womenEvaluation and Program Planning, 2004